Come up with a name for your new list and we'll add to it:
Oncternal Therapeutics raised a round of funding on June 08, 2016. Investors include
Hale BioPharma Ventures.
Oncternal Therapeutics, formerly Tokalas, is a clinical-stage oncology company developing therapies for both rare and common cancers by focusing on targets that are uniquely expressed within cancer ce…